Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ionetix
AddedFeb 15, 2024
UpdatedJun 18, 2026
Ionetix

Ionetix

Series D

IONETIX: A leading American company providing molecular imaging diagnostics and N-13 Ammonia access.

HQ
San Francisco, CA, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to advance molecular imaging diagnostics and therapeutics, IONETIX focuses on providing physicians and patients access to N-13 Ammonia. The company offers cutting-edge diagnostic tools and therapeutic alpha radionuclides for Targeted Alpha Therapy (TAT). Their market focus includes enhancing cardiac PET practices through educational resources and CE credits, aiming to improve clinical outcomes and business opportunities in the medical field.

IONETIX has garnered attention for its innovative approach to molecular imaging and targeted therapies. Notable affiliations include partnerships with leading medical institutions and investment from prominent venture capital firms. Key achievements include the establishment of a new facility dedicated to TAT products and the development of an educational series for cardiac PET practices. Overall, IONETIX has made a significant impact by improving diagnostic accuracy and therapeutic options in the healthcare industry.

Ionetix - Similar Companies

Io Therapeutics logo

Io Therapeutics

Ionix Medical logo

Ionix Medical

NextImage Medical logo

NextImage Medical

Ionica Sciences logo

Ionica Sciences

XRad Therapeutics logo

XRad Therapeutics

IgGenix logo

IgGenix

iggenix.com

Ionpath logo

Ionpath

Eikonizo Therapeutics logo

Eikonizo Therapeutics

eikonizo.com

Prominex logo

Prominex

prominex.com

Amplified Sciences logo

Amplified Sciences

Diagnostic Biochips logo

Diagnostic Biochips

Immvention Therapeutix logo

Immvention Therapeutix

Empowered Diagnostics logo

Empowered Diagnostics

Advanced Chemotherapy Technologies logo

Advanced Chemotherapy Technologies

PanTher Therapeutics logo

PanTher Therapeutics

panthertx.com

Ionetix - Quick Facts

Who are Ionetix's competitors?

Companies similar to Ionetix include Io Therapeutics, Ionix Medical, NextImage Medical and Ionica Sciences.

When was Ionetix founded?

Ionetix was founded in 2010.

Where is Ionetix's headquarters located?

Ionetix's headquarters is located in San Francisco, CA, US.

When was Ionetix's last funding round?

Ionetix's most recent funding round was for $37.3M (USD) in December 2018.

How much has Ionetix raised to-date?

As of Dec 14, 2018, Ionetix has raised a total of $48.8M (USD).

How many employees does Ionetix have?

Ionetix has 66 employees as of Feb 5, 2024.

Ionetix - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostics
  • Therapeutics
Tags
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research